130 related articles for article (PubMed ID: 18215701)
21. Reevaluation of lock solutions for Central venous catheters in hemodialysis: a narrative review.
Wang Y; Sun X
Ren Fail; 2022 Dec; 44(1):1501-1518. PubMed ID: 36047812
[TBL] [Abstract][Full Text] [Related]
22. Comparative Clinical Performances of Tunneled Central Venous Catheters versus Arterio-Venous Accesses in Patients Receiving High-Volume Hemodiafiltration: The Case for High-Flow DualCath, a Tunneled Two-Single-Lumen Silicone Catheter.
Canaud B; Leray-Moragues H; Chenine L; Morena M; Miller G; Canaud L; Cristol JP
J Clin Med; 2023 Jul; 12(14):. PubMed ID: 37510847
[TBL] [Abstract][Full Text] [Related]
23. Pathology of catheter-related complications: what we need to know and what should be discovered.
Wang L; Jia L; Jiang A
J Int Med Res; 2022 Oct; 50(10):3000605221127890. PubMed ID: 36268763
[TBL] [Abstract][Full Text] [Related]
24. REDUcing the burden of dialysis Catheter ComplicaTIOns: a National approach (REDUCCTION) - design and baseline results.
Kotwal S; Coggan S; McDonald S; Talaulikar G; Cass A; Jan S; Polkinghorne KR; Gray NA; Gallagher M
Kidney360; 2020 Aug; 1(8):746-754. PubMed ID: 35372959
[TBL] [Abstract][Full Text] [Related]
25. Central Venous Catheters for Hemodialysis-the Myth and the Evidence.
Sohail MA; Vachharajani TJ; Anvari E
Kidney Int Rep; 2021 Dec; 6(12):2958-2968. PubMed ID: 34901568
[TBL] [Abstract][Full Text] [Related]
26. Locked Away-Prophylaxis and Management of Catheter Related Thrombosis in Hemodialysis.
Szymańska J; Kakareko K; Rydzewska-Rosołowska A; Głowińska I; Hryszko T
J Clin Med; 2021 May; 10(11):. PubMed ID: 34063913
[TBL] [Abstract][Full Text] [Related]
27. Re-Evaluating the Protective Effect of Hemodialysis Catheter Locking Solutions in Hemodialysis Patients.
Chen CH; Chen YM; Yang Y; Chang YJ; Lin LJ; Yen HC
J Clin Med; 2019 Mar; 8(3):. PubMed ID: 30934607
[TBL] [Abstract][Full Text] [Related]
28. Sodium bicarbonate catheter lock solution reduces hemodialysis catheter loss due to catheter-related thrombosis and blood stream infection: an open-label clinical trial.
El-Hennawy AS; Frolova E; Romney WA
Nephrol Dial Transplant; 2019 Oct; 34(10):1739-1745. PubMed ID: 30668833
[TBL] [Abstract][Full Text] [Related]
29. Antimicrobial Efficacy of a New Chlorhexidine-based Device Against Staphylococcus aureus Colonization of Venous Catheters.
Kowalewska PM; Petrik SM; Di Fiore AE; Fox-Robichaud AE
J Infus Nurs; 2018; 41(2):103-112. PubMed ID: 29489705
[TBL] [Abstract][Full Text] [Related]
30. Cluster-Randomized Trial of Devices to Prevent Catheter-Related Bloodstream Infection.
Brunelli SM; Van Wyck DB; Njord L; Ziebol RJ; Lynch LE; Killion DP
J Am Soc Nephrol; 2018 Apr; 29(4):1336-1343. PubMed ID: 29472415
[TBL] [Abstract][Full Text] [Related]
31. Declining comorbidity-adjusted mortality rates in English patients receiving maintenance renal replacement therapy.
Storey BC; Staplin N; Harper CH; Haynes R; Winearls CG; Goldacre R; Emberson JR; Goldacre MJ; Baigent C; Landray MJ; Herrington WG
Kidney Int; 2018 May; 93(5):1165-1174. PubMed ID: 29395337
[TBL] [Abstract][Full Text] [Related]
32. Hemodialysis Tunneled Catheter-Related Infections.
Miller LM; Clark E; Dipchand C; Hiremath S; Kappel J; Kiaii M; Lok C; Luscombe R; Moist L; Oliver M; MacRae J;
Can J Kidney Health Dis; 2016; 3():2054358116669129. PubMed ID: 28270921
[TBL] [Abstract][Full Text] [Related]
33. Practical Aspects of Nontunneled and Tunneled Hemodialysis Catheters.
Clark E; Kappel J; MacRae J; Dipchand C; Hiremath S; Kiaii M; Lok C; Moist L; Oliver M; Miller LM;
Can J Kidney Health Dis; 2016; 3():2054358116669128. PubMed ID: 28270920
[TBL] [Abstract][Full Text] [Related]
34. Bacteremia in hemodialysis patients.
Suzuki M; Satoh N; Nakamura M; Horita S; Seki G; Moriya K
World J Nephrol; 2016 Nov; 5(6):489-496. PubMed ID: 27872830
[TBL] [Abstract][Full Text] [Related]
35. Comparative effectiveness of 30 % trisodium citrate and heparin lock solution in preventing infection and dysfunction of hemodialysis catheters: a randomized controlled trial (CITRIM trial).
Correa Barcellos F; Pereira Nunes B; Jorge Valle L; Lopes T; Orlando B; Scherer C; Nunes M; Araújo Duarte G; Böhlke M
Infection; 2017 Apr; 45(2):139-145. PubMed ID: 27573387
[TBL] [Abstract][Full Text] [Related]
36. APSIC guide for prevention of Central Line Associated Bloodstream Infections (CLABSI).
Ling ML; Apisarnthanarak A; Jaggi N; Harrington G; Morikane K; Thu le TA; Ching P; Villanueva V; Zong Z; Jeong JS; Lee CM
Antimicrob Resist Infect Control; 2016; 5():16. PubMed ID: 27152193
[TBL] [Abstract][Full Text] [Related]
37. A Comparison between Hybrid Therapy and Standard Triple Therapy for Helicobacter pylori Eradication in Patients with Uremia: A Randomized Clinical Trial.
Makhlough A; Fakheri H; Hojati S; Hosseini V; Bari Z
Middle East J Dig Dis; 2016 Jan; 8(1):39-43. PubMed ID: 26933480
[TBL] [Abstract][Full Text] [Related]
38. Antimicrobial lock solutions for the prevention of catheter-related infection in patients undergoing haemodialysis: study protocol for network meta-analysis of randomised controlled trials.
Zhang J; Li RK; Chen KH; Ge L; Tian JH
BMJ Open; 2016 Jan; 6(1):e010264. PubMed ID: 26733573
[TBL] [Abstract][Full Text] [Related]
39. Antibiotic lock for the prevention of catheter-related infection in neonates.
Taylor JE; Tan K; Lai NM; McDonald SJ
Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD010336. PubMed ID: 26040840
[TBL] [Abstract][Full Text] [Related]
40. Antibiotic lock therapy: review of technique and logistical challenges.
Justo JA; Bookstaver PB
Infect Drug Resist; 2014; 7():343-63. PubMed ID: 25548523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
